Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
Open Access
- 1 May 2011
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (5), 990-999
- https://doi.org/10.1038/mt.2010.289
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNAJournal of Immunotherapy, 2008
- Robust CD4+ and CD8+ T cell responses to SIV using mRNA‐transfected DC expressing autologous viral AgEuropean Journal of Immunology, 2007
- BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia CellsCancer Research, 2007
- Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell ResponsesMolecular Therapy, 2006
- Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytesCancer Gene Therapy, 2005
- Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro–transcribed MUC1 RNABlood, 2005
- Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical ResponsesClinical Cancer Research, 2004
- Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell CarcinomaHuman Gene Therapy, 2003
- Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytesGene Therapy, 2003
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990